Trials / Sponsors / Lutris Pharma Ltd.
Lutris Pharma Ltd.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC EGFRI Induced Acneiform Lesions | Phase 2 | 2021-04-12 |
| Completed | LUT014 for the Treatment of Radiation Induced Dermatitis in Breast Cancer Patients Radiation Dermatitis | Phase 1 / Phase 2 | 2021-01-30 |
| Completed | A Study of LUT014 in Patients With Metastatic Colorectal Cancer With EGFR Inhibitor Induced Acneiform Lesions EGFR Inhibitor Induced Acneiform Lesions | Phase 1 | 2019-08-21 |